Manufacturing Readiness Is The Next Frontier In Life Sciences AI

By Nikki Bishop, Emerson

AI-accelerated molecules are reaching manufacturing sites with less runway and more complexity than the process was built for, while GMP and validation standards haven't moved. Tech transfer is the first point where that pressure shows, and an industry consortium is already working to standardize how process knowledge moves between development and the plant. The batch record, usually filed under compliance, may be the richest dataset a site owns. AI expert Noelle Russell's argument that trustworthy AI rests on data integrity gives that point added weight. Three closing questions let you test how your own chain would hold if a molecule arrived 18 months early. Read why readiness has to be built before the molecules arrive.